Skip to main content

#151014

MCF7 AREc32 Cell Line

Cat. #151014

MCF7 AREc32 Cell Line

Cat. #: 151014

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Breast

Disease: Cancer

Model: Reporter

£800.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Roland Wolf

Institute: University of Dundee

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: MCF7 AREc32 Cell Line
  • Research fields: Cancer;Drug development
  • Tool sub type: Continuous
  • Parental cell: MCF7
  • Organism: Human
  • Tissue: Breast
  • Disease: Cancer
  • Model: Reporter
  • Conditional: Yes
  • Description: Cell line used to investigate ARE gene expression.Background and Research ApplicationThe stable human mammary MCF7-derived reporter cell line called AREc32 contains copies of the rat GST antioxidant response element (ARE) linked to a luciferase gene, such that the induction of the ARE results in luciferase activity. ARE is a transcriptional cis-regulatory element involved in the activation of genes coding for a number of antioxidant proteins and enzymes that work in concert to protect tissues from oxidative insults. This cell line can be used to investigate whether anti-cancer drugs can induce ARE-driven gene expression.
  • Production details: The ARE-luciferase reporter plasmid was generated using the pGL3-promoter vector containing an SV40 promoter upstream of the firefly luciferase gene. They differ in the number of copies of ARE sequences that have been inserted, in head-to-tail orientation, through Nhe I & Xho I restrictionsites upstream of the promoter-luc+ transcriptional unit. A plasmid was made containing eight copies of the ARE (5'-GTGACAAAGCA-3', with the minimal functional sequence underlined) present in both rat GSTA2 ...
  • Biosafety level: 1
  • Recommended controls: MCF7 parental line
  • Cellosaurus id: CVCL_1D32

Target Details

  • Target: Antioxidant Response Element (ARE)- Luciferase

Handling

  • Format: Frozen
  • Growth medium: DMEM with 2.5mM Glutamax supplemented with 10% fetal bovine serum. Do not culture beyond 15 passages after revival.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Subculture routine: Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4 x 10^4 cells/cm² using 0.05% trypsin/EDTA solution. Cells are cultured at 37°C, in 95% air and 5% CO₂, and passaged every 3 to 4 days.
  • Mycoplasma free: Yes

References

  • Gameiro et al. 2017. Sci Rep. 7:45701. PMID: 28361919.
  • Discovery of the first dual GSK3? inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease.
  • MacLeod et al. 2016. Br J Cancer. :. PMID: 27824809.
  • Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
  • Basar et al. 2016. Phytochem Anal. 27(5):233-8. PMID: 27527356.
  • Utilization of the Ability to Induce Activation of the Nuclear Factor (Er...

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.